University of Miami Miller School of Medicine researchers have identified molecular evidence linking human papillomavirus ...

In 2023, The Good Bug secured $3.5 million in a Series A funding round led by Fireside Ventures, with participation from Think9 Consumer Technologies and Sharrp Ventures, the family office of ...

Luxturna, a treatment for LCA caused by mutations in the RPE65 gene, was the first gene therapy approved in the US in 2017 for a genetic disease. To the FDA ... another company developing treatments ...

The latest biotech to roll out of Third Rock Ventures is working on Fc-based therapeutics it hopes could offer new treatment options to patients with autoimmune disorders like Graves' disease.

With its lead program, Merida is targeting Graves’ disease, an autoimmune disorder that attacks the thyroid. The condition is characterized by autoantibodies binding to thyroid-stimulating hormone ...

While most aren't serious, eyelids can also swell due to a medical condition such as Graves' disease, a thyroid-related condition that requires long-term treatment. Symptoms can affect one eye or both ...

During the active phase of TED, some patients present with mild symptoms (soft tissue involvement and lid retraction) and others with more serious ocular complications, such as proptosis (exophthalmos ...

Introduction: Graves´ disease (GD) is the predominant cause of hyperthyroidism. Treatment options include antithyroid drugs (ATD), surgery, and radioactive iodine ablation (RI). Although thyroid ...

Reproxalap, a reactive aldehyde species modulator, is approved for dry eye disease, reducing ocular redness. A phase 3 trial with 132 patients confirmed reproxalap's efficacy over a control in ...

At 8, she was diagnosed with Coats' disease, a rare, congenital eye disorder that left her left eye permanently blind and required surgery to stop the leaking of her blood vessels. At 10 ...